UK fraud office probes GSK after claims of foreign bribery

By Ben Hirschler LONDON (Reuters) - Britain's fraud office has launched a formal criminal investigation into GlaxoSmithKline, posing a new challenge to the drugmaker, which already faces claims of bribery in China and four other countries. The Serious Fraud Office (SFO) said late on Tuesday that its director had "opened a criminal investigation into the commercial practices of GlaxoSmithKline and its subsidiaries", confirming an earlier brief statement from the company. "GSK is committed to operating its business to the highest ethical standards and will continue to cooperate fully with the SFO," the company said. Neither the SFO nor GSK gave any further details about the case, and a company spokesman declined to elaborate.

via Health News Headlines - Yahoo News Read More Here..